China Biotech Services Holdings Ltd. has announced key management changes. Liu Xiaolin continues as Chairman and Executive Director. The company appointed a new executive director and made changes in independent non-executive directors. The audit committee's composition and the company secretary have also been updated.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.